Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -10994.73% is 4840% below its 5-year average of -222.58%, around the middle of its 5-year range (-18633.14%–-82.96%).
12.14% below its 12-month average of -9804.81%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -18633.14%.
NET PROFIT MARGIN
-10994.73%
NET PROFIT MARGIN AVG TTM
-9804.81%
NET PROFIT MARGIN AVG 3Y
-2685.26%
NET PROFIT MARGIN AVG 5Y
-222.58%
NET PROFIT MARGIN AVG 10Y
-431.78%
NET PROFIT MARGIN AVG 15Y
-497.77%
NET PROFIT MARGIN AVG 20Y
-474.46%
CURRENT VS TTM AVG
-12.14%
CURRENT VS 3Y AVG
-309.45%
CURRENT VS 5Y AVG
-4839.61%
CURRENT VS 10Y AVG
-2446.35%
CURRENT VS 15Y AVG
-2108.80%
CURRENT VS 20Y AVG
-2217.33%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 526 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
EyePoint Pharmaceuticals, Inc.
Market Cap
$262.42M
Net Profit Margin
-10994.73%
TTM Avg
-9804.81%
3Y Avg
-2685.26%
5Y Avg
-222.58%
Market Cap
$262.40M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-5482.65%
5Y Avg
-3802.53%
Market Cap
$261.64M
Net Profit Margin
-3.14%
TTM Avg
-28.33%
3Y Avg
-34.54%
5Y Avg
-25.62%
Market Cap
$264.37M
Net Profit Margin
-8.78%
TTM Avg
-964.82%
3Y Avg
-2640.79%
5Y Avg
-1760.53%
Market Cap
$264.62M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2265.94%
5Y Avg
-2185.44%
Market Cap
$259.30M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$274.28M
Net Profit Margin
-249.94%
TTM Avg
-1079.05%
3Y Avg
-1080.63%
5Y Avg
-787.30%
Market Cap
$278.05M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$246.30M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | $262.42M | -10994.73% | -9804.81% | -2685.26% | -222.58% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $262.40M | 0.00% | 0.00% | -5482.65% | -3802.53% |
| Anika Therapeutics, Inc. (ANIK)vs › | $261.64M | -3.14% | -28.33% | -34.54% | -25.62% |
| Century Therapeutics, Inc. (IPSC)vs › | $264.37M | -8.78% | -964.82% | -2640.79% | -1760.53% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $264.62M | 0.00% | 0.00% | -2265.94% | -2185.44% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| AC Immune S.A. (ACIU)vs › | $274.28M | -249.94% | -1079.05% | -1080.63% | -787.30% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $278.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $246.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aurora Cannabis Inc. (ACB)vs › | $277.81M | -38.13% | -18.76% | -107.01% | -249.44% |
Operating Margin
-776.0%
Net Profit Margin
-10994.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -18633.14% |
| 2026-03-31 | -12188.51% |
| 2025-12-31 | -10904.68% |
| 2025-09-30 | -6183.44% |
| 2025-06-30 | -1114.31% |
| 2025-03-31 | -184.82% |
| 2024-12-31 | -357.26% |
| 2024-09-30 | -278.99% |
| 2024-06-30 | -325.27% |
| 2024-03-31 | -250.63% |
| 2023-12-31 | -100.51% |
| 2023-09-30 | -82.96% |
| 2023-06-30 | -251.73% |
| 2023-03-31 | -275.47% |
| 2022-12-31 | -412.53% |
| 2022-09-30 | -183.98% |
| 2022-06-30 | -167.80% |
| 2022-03-31 | -225.69% |
| 2021-12-31 | -168.33% |
| 2021-09-30 | -184.29% |
| 2021-06-30 | -111.06% |
| 2021-03-31 | -167.69% |
| 2020-12-31 | -216.93% |
| 2020-09-30 | -24.22% |
| 2020-06-30 | -314.17% |
| 2020-03-31 | -175.91% |
| 2019-12-31 | -120.58% |
| 2019-09-30 | -623.63% |
| 2019-06-30 | -159.47% |
| 2019-03-31 | -956.16% |
| 2018-12-31 | -474.77% |
| 2018-09-30 | -6816.05% |
| 2018-06-30 | -4815.10% |
| 2018-03-31 | -751.94% |
| 2017-12-31 | -619.72% |
| 2017-09-30 | -1554.03% |
| 2017-06-30 | -872.47% |
| 2017-03-31 | -871.19% |
| 2016-12-31 | -1.12% |
| 2016-09-30 | -2585.56% |
| 2016-06-30 | -2100.99% |
| 2016-03-31 | -1555.86% |
| 2015-12-31 | -985.93% |
| 2015-09-30 | -1058.58% |
| 2015-06-30 | -1258.19% |
| 2015-03-31 | -1523.78% |
| 2014-12-31 | -782.15% |
| 2014-09-30 | 81.27% |
| 2014-06-30 | -1358.56% |
| 2014-03-31 | -109.79% |
| 2013-12-31 | -593.58% |
| 2013-09-30 | -617.59% |
| 2013-06-30 | -802.24% |
| 2013-03-31 | -544.64% |
| 2012-12-31 | -445.81% |
| 2012-09-30 | -461.30% |
| 2012-06-30 | -323.61% |
| 2012-03-31 | -499.26% |
| 2011-12-31 | 790.76% |
| 2011-09-30 | -146.29% |
| 2011-06-30 | -3.77% |
| 2011-03-31 | -745.83% |
| 2010-12-31 | -650.97% |
| 2010-09-30 | -652.94% |
| 2010-06-30 | 83.15% |
| 2010-03-31 | -525.24% |
| 2009-12-31 | -0.70% |
| 2009-09-30 | -47.03% |
| 2009-06-30 | -4.08% |
| 2009-03-31 | -20.11% |
| 2008-12-31 | -29.29% |
| 2008-09-30 | -16.79% |
| 2008-06-30 | -2352.16% |
| 2008-03-31 | -1014.94% |
| 2007-12-31 | -4527.34% |
| 2007-09-30 | -771.84% |
| 2007-06-30 | -2953.63% |
| 2007-03-31 | -13393.85% |
| 2006-12-31 | -22192.49% |
| 2006-09-30 | 4751.98% |
| 2006-06-30 | -986.91% |
| 2006-05-11 | -1597.97% |
| 2005-12-31 | -859.51% |
| 2005-11-30 | -1597.96% |
| 2005-06-30 | -1776.46% |
| 2005-03-31 | -1776.48% |
| 2004-12-31 | -1776.47% |
| 2004-09-30 | -1776.47% |
| 2004-06-30 | -965.01% |
| 2004-03-31 | -964.99% |
| 2003-12-31 | -965.00% |
| 2003-09-30 | -965.00% |
| 2003-06-30 | -539.99% |
| 2003-03-31 | -2498.37% |
| 2002-12-31 | -2498.47% |
| 2002-09-30 | -2498.46% |
